Chronic Granulomatous Disorder-Associated Colitis Can Be Accurately Evaluated with MRI Scans and Fecal Calprotectin Level.
David M LowePhilip J SmithFernando MoreiraSarita WorkmanHelen BragginsNikolaos KoukiasMatthew S BucklandPeter WylieStuart A TaylorCharles D MurrayPublished in: Journal of clinical immunology (2019)
MRI and fecal calprotectin are useful methods for monitoring CGD colitis and should reduce the need for colonoscopy in these patients. IL-12 may represent an appropriate target for treatment.
Keyphrases
- contrast enhanced
- end stage renal disease
- magnetic resonance imaging
- ejection fraction
- newly diagnosed
- computed tomography
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- diffusion weighted imaging
- disease activity
- ulcerative colitis
- systemic lupus erythematosus
- systemic sclerosis
- patient reported
- colorectal cancer screening